viernes, 18 de abril de 2014

CDC - Blogs - Genomics and Health Impact Blog – Public Health Genomics to Save Lives: Available Tools, Actual Examples, Real Success

CDC - Blogs - Genomics and Health Impact Blog – Public Health Genomics to Save Lives: Available Tools, Actual Examples, Real Success

Public Health Genomics to Save Lives: Available Tools, Actual Examples, Real Success

Categories: genomicspublic health

Announcing New Tier 1 CDC Public Health Genomics Toolkit and Video Resources

Impact… ScalabilityExternal Web Site Icon… Innovation… Evidence-based interventions… Surveillance and evaluation… Partnerships… Timely information to health care, the public, and decision makers… CommitmentExternal Web Site Icon… These elements are crucial to any public health accomplishment and are recurring themes in 2 new public health genomics resources.
Nearly 2 million people in the United States are at increased risk for adverse health outcomes due to one of the following conditions Lynch syndrome (LS), hereditary breast/ovarian cancer (HBOC), and familial hypercholesterolemia (FH).  Because, at present, these conditions are poorly ascertained by the healthcare system, many individuals and families affected by them are not aware that they are at risk; however, early detection and intervention could significantly reduce morbidity and mortality. Because of their unique ability to partner, facilitate, and provide leadership across the health sector, public health departments have important roles to play in reducing the burden of these conditions.
1. Set Goals by Assessing Data and Available Resources 2. Build Partnerships 3. Conduct Surveillance 4. Provide Info to Policy Makers 5. Make Education Available to the Public 6. Implement Bi-directional Reporting 7. Conduct Surveillance and Assess Results
7 steps for public health to use genomics to reduce the burden of cancer & heart disease
Public health genomics implementation to save lives – from national vision to state successExternal Web Site Icon  is a video produced in partnership  with Genetic Alliance featuring prominent public health and health care provider, payer, and patient leaders.  The web available program provides a scope that moves from the national vision for impact to actual achievement in one specific state example: Michigan.  The video includes a primary focus on LS and HBOC and includes specific key steps to be taken, the crucial importance of partners, lessons learned, results, and next steps.
The new CDC Toolkit focuses on specific evidence-based applications to prevent cancer and heart disease for persons at risk from LS, HBOC, and FH and provides key background information, tools and real world examples to help states to develop or build upon existingTier 1 programs.  The Toolkit is designed to include the materials of greatest interest to states but also provides links to much more detailed resources.  As an example one of the tools included is another video: Tier I Genomic Applications and Pioneer StatesExternal Web Site Icon which provides useful information for state health department personnel interested in implementing Tier 1 genomic applications. The video features informal interviews by Sharon Terry of Genetic Alliance with state health department pioneers in ConnecticutExternal Web Site IconOregonExternal Web Site Icon, and MichiganExternal Web Site Icon.
While the potential of the three applications highlighted in the Toolkit is great there areseveral other Tier 1 applications which are yet to be fully explored in practice.  As the field evolves, the Office of Public Health Genomics will continue to update and expand the Tier 1 applications table and the Toolkit. We are interested in getting input and feedback about these tools and what to include in future editions of the Toolkit.
Francis Collins, Muin Khoury, Bob Croyle and Janice Bach
Dr. Francis Collins, Director, NIH; Dr. Muin Khoury, Director, Office of Public Health Genomics, CDC; Dr. Robert T. Croyle, Director, Division of Cancer Control and Population Sciences, NIH; Janice Bach; MS, CGC, Michigan Department of Community Health
Debra Duquette, Elena M. Stoffel, Sarah Mange, Jenna McLosky,Richard Murdock, Polly Hager, Lindsay Dohany and Angela Trepanier
It takes partnerships: Debra Duquette, MS, CGC, Michigan Department of Community Health; Elena M. Stoffel, MD, MPH, Director, Cancer Genetics Clinic, University of Michigan Health System; Sarah Mange, MPH, Cancer Genetics Epidemiologist; Jenna McLosky, MS, CGC, Cancer Genomics Education Coordinator; Richard Murdock, Executive Director, Michigan Association of Health Plans; Polly Hager, MSN, RN, Managing Director, Comprehensive Cancer Control Program Director, Michigan Department of Community Health Foundation; Lindsay Dohany, MS, CGC, Genetic Counselor, Beaumont Health System; Angela Trepanier, MS, CGC, Director, Genetic Counseling Graduate Program, Assistant Professor, Center for Molecular Medicine and Genetics Wayne State
Juan Rodriguez and Katrina F Trivers
Juan Rodriguez, MPH, MS, Division of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion, CDC and Katrina F Trivers, PhD, MSPH, CDC Division of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Heath Promotion, CDC
Nancy Petrucelli and Julie Zenger Hain
Nancie Petrucelli, MS, CGC, Senior Genetic Counselor/Coordinator, Cancer Genetic Counseling Service, Kamanos Cancer Institute and Julie Zenger Hain, Ph.D, Director, Clinical Cytogenetics of the Oakwood Health System

No hay comentarios:

Publicar un comentario